Received: 21 July 2020
Accepted: 7 October 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: Approval to carry out the study was obtained by the CPA board of trustees. Ethics Committee was not required because this is a service evaluation. All respondents participated strictly in their professional capacity, and their participation in the survey was in all cases on the basis of informed consent.
: Not applicable.
: Two authors declare the following competing interests: DAO is technical programme lead for Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme. ZB is the Editor of <i>Journal of Pharmaceutical Policy and Practice</i>. All other authors declare no competing interests.